Intimation of Appointment of Additional non executive non independent director.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals Ltd (formerly Trimurthi Limited) has appointed Mr. Jivamohan Divakar Valluri as an Additional Director (Non-Executive Non-Independent) on its board, effective April 12, 2025. The appointment was approved by the Board at its meeting held the same day and is subject to shareholder approval. Mr. Valluri holds a Master's in English Literature and has a career background primarily in journalism — including roles at Indian Express, Deccan Chronicle, Times of India, and currently as Editor at Metro India English Daily. He has no prior pharmaceutical industry experience and is not related to any existing director, KMP, or promoter of the company. This is the only board-level change disclosed in the filing.
For shareholders, this adds a non-executive non-independent director with a media/journalism background rather than pharmaceutical expertise. Since the appointee is not related to promoters and no other governance red flags are mentioned, the immediate impact on the stock price is likely neutral. Shareholders should watch for the shareholder approval outcome in the upcoming AGM.